United Therapeutics | Stammkapital





Stammkapital Veränderung Datum
Amarin USD 20.8M 28K 2025-09
Ardelyx USD 238.02M 1.13M 2024-12
Baxter International USD 683M 0 2024-12
Bayer EUR 982.42M 0 2025-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.03B 119.13M 2025-09
Halozyme Therapeutics USD 117.52M 98K 2025-09
Insmed USD 212.58M 210.76M 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
J&J USD 2.41B 584K 2025-09
Moderna USD 391M 2M 2025-09
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 79.93M 554K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
United Therapeutics USD 42.9M 42.1M 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


United Therapeutics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.